Stock listing
NYSE:MYOV Myovant Sciences Ltd Stock
Follow Myovant Sciences Ltd into a list and get an email when it puts out news.
Last close · NYSE:MYOV
$26.98 USD
Close on Mar 9, 2023 · No longer trades
- Lowest – highest close
- $4.20 – $27.62 USDSince Oct 27, 2016 · lowest Oct 28, 2019 · highest Dec 31, 2020
Delisted NYSE:MYOV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:MYOV
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
Myovant Sciences Ltd on 6ix
- Decks
- 1 deck · latest May 14, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (May 2019) | Technical | 21 slides | May 14, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Myrtle S Potter Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Since at least Jun 13, 2024); Guardant Health, Inc. (Director · Since at least Oct 15, 2021); Immunovant, Inc. (Director · Dec 18, 2019 – Dec 18, 2019 · Past); Arbutus Biopharma Corporation (Director · Oct 18, 2018 – Aug 17, 2019 · Past); Sio Gene Therapies Inc (Director · Sep 26, 2018 – Apr 15, 2019 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Axsome Therapeutics, Inc. (Director · Jun 16, 2017 – Jun 7, 2019 · Past); Insmed Incorporated (Director · Dec 11, 2014 – May 15, 2018 · Past); Everyday Health Inc (Director · Mar 27, 2014 – Dec 3, 2016 · Past); Rite Aid Corporation (Director · Nov 29, 2013 – Oct 3, 2017 · Past) | Director · Sep 20, 2018 – Mar 10, 2023 · Past |
| Lynn Seely Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Lyell Immunopharma, Inc. (President and CEO, Director · Since at least Jun 16, 2021); Blueprint Medicines Corp (Director · Since at least Jun 19, 2019) | Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past |
| Matthew Lang Other companies: Structure Therapeutics, Inc. (COO & GC · Since at least Apr 15, 2026); Metsera, Inc. (CHIEF LEGAL OFFICER · Since at least Apr 28, 2025); Lyell Immunopharma, Inc. (Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past) | General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past |
| Kim Sablich Other companies: Eiger Biopharmaceuticals Inc (Director · Apr 23, 2021 – Mar 1, 2023 · Past); Jazz Pharmaceuticals plc (EVP, GM of U.S. · Jun 1, 2020 – Jun 5, 2023 · Past) | Chief Commercial Officer · Dec 1, 2018 – Apr 3, 2020 · Past |
| Mark Altmeyer Other companies: Alector, Inc. (Board Member · Since at least Mar 19, 2024); Sio Gene Therapies Inc (Pres (ASG) & Chief Comm. Ofc. · Jun 10, 2015 – Mar 15, 2018 · Past) | Director · Oct 26, 2016 – Aug 31, 2018 · Past |
| Marianne L Romeo Other companies: Sio Gene Therapies Inc (Head,Global Trans & Risk Mgmt, Director · Apr 29, 2016 – Apr 29, 2016 · Past) | Head,Global Trans. & Risk Mgmt · Oct 26, 2016 – Oct 26, 2016 · Past |
Log in to ask 6ix AI your own questions about Myovant Sciences Ltd.